Andre Bollacke
Overview
Explore the profile of Andre Bollacke including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
105
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rumler H, Schmithals C, Werner C, Bollacke A, Aichele D, Gotz C, et al.
ACS Pharmacol Transl Sci
. 2024 Dec;
7(12):3846-3866.
PMID: 39698287
The human protein kinase CK2 is a promising target for cancer treatment. Only two CK2 inhibitors have reached clinical trials until today. Among others, a dibenzofuran scaffold has emerged as...
2.
Schnitzler A, Gratz A, Bollacke A, Weyrich M, Kucklander U, Wunsch B, et al.
Pharmaceuticals (Basel)
. 2018 Feb;
11(1).
PMID: 29462988
Human protein kinase CK2 is an emerging target for neoplastic diseases. Potent lead structures for human CK2 inhibitors are derived from dibenzofuranones. Two new derivatives, 7,9-dichloro-1,2-dihydro-8-hydroxy-4-[(4-methoxyphenylamino)-methylene]dibenzo[,]furan-3(2)-one () and ()-1,3-dichloro-6-[(4-methoxyphenylimino)-methyl]dibenzo[,]furan-2,7-diol ()...
3.
Nacereddine A, Bollacke A, Roka E, Marminon C, Bouaziz Z, Fenyvesi F, et al.
Pharmaceuticals (Basel)
. 2018 Jan;
11(1).
PMID: 29373552
Since the approval of imatinib in 2001, kinase inhibitors have revolutionized cancer therapies. Inside this family of phosphotransferases, casein kinase 2 (CK2) is of great interest and numerous scaffolds have...
4.
Nienberg C, Garmann C, Gratz A, Bollacke A, Gotz C, Jose J
Pharmaceuticals (Basel)
. 2017 Jan;
10(1).
PMID: 28067769
Human protein kinase CK2 has emerged as promising target for the treatment of neoplastic diseases. The vast majority of kinase inhibitors known today target the ATP binding site, which is...
5.
Bollacke A, Nienberg C, Le Borgne M, Jose J
J Pharm Biomed Anal
. 2016 Jan;
121:253-260.
PMID: 26786382
Human protein kinase CK2 is an emerging target for the development of novel anti-cancer therapeutics. CK2 is a tetramer composed of two catalytically active α- and/or α'-subunits, bound to a...
6.
Gozzi G, Bouaziz Z, Winter E, Daflon-Yunes N, Honorat M, Guragossian N, et al.
Drug Des Devel Ther
. 2015 Jul;
9:3481-95.
PMID: 26170632
Ketonic indeno[1,2-b]indole-9,10-dione derivatives, initially designed as human casein kinase II (CK2) inhibitors, were recently shown to be converted into efficient inhibitors of drug efflux by the breast cancer resistance protein...
7.
Alchab F, Ettouati L, Bouaziz Z, Bollacke A, Delcros J, Gertzen C, et al.
Pharmaceuticals (Basel)
. 2015 Jun;
8(2):279-302.
PMID: 26061121
Due to their system of annulated 6-5-5-6-membered rings, indenoindoles have sparked great interest for the design of ATP-competitive inhibitors of human CK2. In the present study, we prepared twenty-one indeno[1,2-b]indole...
8.
Gratz A, Bollacke A, Stephan S, Nienberg C, Le Borgne M, Gotz C, et al.
Microb Cell Fact
. 2015 Jun;
14:74.
PMID: 26036951
Background: Human protein kinase CK2 represents a novel therapeutic target for neoplastic diseases. Inhibitors are in need to explore the druggability and the therapeutic options of this enzyme. A bottleneck...
9.
Gozzi G, Bouaziz Z, Winter E, Daflon-Yunes N, Aichele D, Nacereddine A, et al.
J Med Chem
. 2014 Oct;
58(1):265-77.
PMID: 25272055
A series of indeno[1,2-b]indole-9,10-dione derivatives were synthesized as human casein kinase II (CK2) inhibitors. The most potent inhibitors contained a N(5)-isopropyl substituent on the C-ring. The same series of compounds...
10.
Bouaziz Z, Issa S, Gentili J, Gratz A, Bollacke A, Kassack M, et al.
J Enzyme Inhib Med Chem
. 2014 Apr;
30(2):180-8.
PMID: 24697298
Four series of carbazole derivatives, including N-substituted-hydroxycarbazoles, oxazinocarbazoles, isoxazolocarbazolequinones, and pyridocarbazolequinones, were studied using diverse biological test methods such as a CE-based assay for CK2 activity measurement, a cytotoxicity assay...